CTVA
Get informed when a big investor buys or sells
+ FollowJuly 31, 2026 - AI Summary
Undervalued by 97.9% based on the discounted cash flow analysis.
| Market cap | $51.39 Billion |
|---|---|
| Enterprise Value | $54.58 Billion |
| Dividend Yield | $0.72 (0.94%) |
| Earnings per Share | $1.6 |
| Beta | 0.56 |
| Outstanding Shares | 670,400,000 |
| P/E Ratio | 50.88 |
|---|---|
| PEG | -436.98 |
| Price to Sales | 2.92 |
| Price to Book Ratio | 2.05 |
| Enterprise Value to Revenue | 3.06 |
| Enterprise Value to EBIT | 29.79 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.22 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.3077▲ 106.62% |
|---|---|
| Total Calls | 14,300▼ 98.60% |
| Total Puts | 18,700▼ 92.44% |
Holdings and activity of institutional investors.
| Ownership % | 22.16%▼ 64.04% |
|---|---|
| Total Invested | $12.59B▼ 73.99% |
| Investors Holding | 897▼ 605.00% |
No data
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...